DIANA JIMENEZ: Open Payments
NPI 1144932971 · PEMBROKE PINES, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$748 in 40 payments from 12 companies in 2025. Trend: 2023 $894 · 2024 $846 · 2025 $748
Food & beverage: $748
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 7 | $144 |
| Novo Nordisk Inc | 7 | $142 |
| Amgen Inc. | 10 | $139 |
| Exact Sciences Corporation | 3 | $81 |
| Lilly USA, LLC | 4 | $71 |
| Dexcom, Inc. | 2 | $41 |
| ABBVIE INC. | 2 | $34 |
| IBSA Pharma Inc. | 1 | $24 |
| PFIZER INC. | 1 | $23 |
| Abbott Laboratories | 1 | $20 |
Products named: AIRSUPRA, OTEZLA, Ozempic, Cologuard Collection Kit, MOUNJARO, REPATHA, Dexcom G6 Transmitter, Wegovy.
Industry payments across FL — which companies pay providers there.
